Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenases in cancer: progress and perspective.

Shan Zha1, Vasan Yegnasubramanian, William G Nelson

  • 1Brady Urological Institute, The Johns Hopkins University, Baltimore, MD, USA.

Cancer Letters
|September 18, 2004
PubMed
Summary

Long-term aspirin use and non-steroidal anti-inflammatory drugs (NSAIDs) show promise in cancer prevention by targeting cyclooxygenase (COX) enzymes, particularly COX-2. Research explores COX enzymes

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ku70-SAP domain has an overlapping function with DNA-PKcs in limiting the lateral movement of the Ku ring along DNA.

Nucleic acids research·2026
Same author

ATM-kinase deficiency triggers early multi-compartment remodeling of the cerebellar microenvironment.

Acta neuropathologica communications·2026
Same author

PARP1-mediated 5' flap dynamics facilitate Okazaki fragment maturation.

bioRxiv : the preprint server for biology·2026
Same author

HLA Class I Expression is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer.

Molecular cancer research : MCR·2026
Same author

Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly-Expressed, Combinatorial Therapeutic Target.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Castration Resistance Accelerates Prostate Cancer Kinetics.

The Prostate·2026

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Epidemiological studies since the 1980s link aspirin use to reduced colorectal cancer incidence.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) targeting cyclooxygenase (COX) enzymes, especially COX-2, are associated with reduced cancer risk in various tissues.
  • Overexpression of COX-2 and prostaglandin pathway enzymes is observed in multiple cancer types, suggesting a role in carcinogenesis.

Purpose of the Study:

  • To review the fundamental features of COX enzymes in relation to carcinogenesis.
  • To examine COX enzyme expression and function in animal tumor models and human cancers.
  • To discuss proposed mechanisms underlying the role of COX enzymes in cancer development and potential therapeutic strategies.

Main Methods:

Related Experiment Videos

  • Review of epidemiological studies on NSAID use and cancer incidence.
  • Analysis of research on COX enzyme overexpression in various cancers.
  • Examination of proposed molecular mechanisms involving prostaglandins, cellular survival, and angiogenesis.
  • Investigation of COX enzyme inhibitors and their impact on understanding COX-2 function and NSAID mechanisms.

    • Main Results:

    • NSAIDs, particularly aspirin, demonstrate potential in cancer prevention and treatment.
    • COX-2 is identified as a significant target for cancer prevention and therapy.
    • Prostaglandins mediated by COX-2 may enhance cellular survival and angiogenesis, promoting cancer.
    • Development of COX inhibitors has advanced the understanding of COX-2's role and revealed COX-independent NSAID functions.

    Conclusions:

    • COX enzymes, especially COX-2, are crucial targets in cancer prevention and therapy.
    • Understanding COX pathways and prostaglandin signaling is key to developing novel cancer treatments.
    • NSAIDs offer valuable insights into cancer biology and drug design, including COX-independent effects.